A comparative characterization of estrogens used in hormone therapy via estrogen receptor (ER)-α and -β.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Steroid Biochemistry and Molecular Biology

• Publication date

  2017-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jsbmb.2017.07.022PMID 28743541
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endogenous thrombin potential changes during the first cycle of oral contraceptive use.

  2017cited by this paper
• Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer

  2016cited by this paper
• Menopause and hormone replacement therapy

  2015cited by this paper
• J. Strauss, R. Barbieri, editors. Yen & Jaffe's Reproductive Endocrinology Seventh Edition. Physiology, Pathophysiology, and Clinical Management. Expert Consult – Online and Print. Elsevier Saunders, Philadelphia, 2014. 976 pp. ISBN: 9781455727582. €159.

  2015cited by this paper
• Divide and Conquer May Not Be the Optimal Approach to Retain the Desirable Estrogenic Attributes of the Cyclopia Nutraceutical Extract, SM6Met

  2015cited by this paper
• Use of medroxyprogesterone acetate for hormone therapy in postmenopausal women: is it safe?

  2014cited by this paper
• 17β-Estradiol treatment inhibits breast cell proliferation, migration and invasion by decreasing MALAT-1 RNA level.

  2014cited by this paper
• A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A).

  2014cited by this paper
• Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action.

  2014cited by this paper
• Effects of estriol on growth, gene expression and estrogen response element activation in human breast cancer cell lines.

  2014cited by this paper
• Cyclopia Extracts Act as ERα Antagonists and ERβ Agonists, In Vitro and In Vivo

  2013cited by this paper
• Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.

  2013cited by this paper
• Estrogen receptor β agonists affect growth and gene expression of human breast cancer cell lines.

  2013cited by this paper
• Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy.

  2013cited by this paper
• Long term hormone therapy for perimenopausal and postmenopausal women.

  2012cited by this paper
• Misconception and concerns about bioidentical hormones used for custom-compounded hormone therapy.

  2012cited by this paper
• Glucocorticoid-independent repression of tumor necrosis factor (TNF) alpha-stimulated interleukin (IL)-6 expression by the glucocorticoid receptor: a potential mechanism for protection against an excessive inflammatory response.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Activation of Estrogen-Responsive Genes Does Not Require Their Nuclear Co-Localization

  2010cited by this paper
• Efficacy of contraceptive methods: A review of the literature

  2010cited by this paper
• Comparison of relative binding affinities to fish and mammalian estrogen receptors: the regulatory implications.

  2010cited by this paper
• Bacterial vaginosis: update on evidence-based care.

  2010cited by this paper
• Regulation of C/EBPbeta1 by Ras in mammary epithelial cells and the role of C/EBPbeta1 in oncogene-induced senescence

  2010cited by this paper
• A Role for Methyl-CpG Binding Domain Protein 2 in the Modulation of the Estrogen Response of pS2/TFF1 Gene

  2010cited by this paper
• Drug and Cell Type-Specific Regulation of Genes with Different Classes of Estrogen Receptor β-Selective Agonists

  2009cited by this paper
• Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells.

  2009cited by this paper
• Bioidentical hormones for maturing women.

  2009cited by this paper
• Anchorage-independent cell growth signature identifies tumors with metastatic potential

  2009cited by this paper
• CHAPTER 4 – The Synthesis and Metabolism of Steroid Hormones

  2009cited by this paper
• Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells

  2009cited by this paper
• Bioidentical Hormones, Compounding, and Evidence-Based Medicine: What Women's Health Practitioners Need to Know

  2009cited by this paper
• Estrogen receptor β: an overview and update

  2008cited by this paper
• Bioidentical Hormones for Menopausal Therapy

  2008cited by this paper
• Hormone replacement therapy and the risk of breast cancer.

  2008cited by this paper
• The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status

  2008cited by this paper
• Bioidentical hormone therapy: a panacea that lacks supportive evidence

  2008cited by this paper
• Evaluation of the phytoestrogenic activity of Cyclopia genistoides (honeybush) methanol extracts and relevant polyphenols.

  2007cited by this paper
• Visualizing the action of steroid hormone receptors in living cells

  2007cited by this paper
• The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial

  2007cited by this paper
• Bioidentical Hormone Therapy: A Review of the Evidence

  2007cited by this paper
• Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.

  2006cited by this paper
• A comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risks.

  2006cited by this paper
• Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.

  2006cited by this paper
• Impact of Estrogen Receptor β on Gene Networks Regulated by Estrogen Receptor α in Breast Cancer Cells

  2006cited by this paper
• Breast cancer risk in relation to different types of hormone replacement therapy in the E3N‐EPIC cohort

  2005cited by this paper
• Hormone replacement therapy, cancer, controversies, and women’s health: historical, epidemiological, biological, clinical, and advocacy perspectives

  2005cited by this paper
• Bioidentical estrogens : Hope or hype?

  2005cited by this paper
• Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion.

  2004cited by this paper
• Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting

  2004cited by this paper
• Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.

  2004cited by this paper
• Bioidentical hormone therapy: a review

  2004cited by this paper
• Rapid yeast estrogen bioassays stably expressing human estrogen receptors alpha and beta, and green fluorescent protein: a comparison of different compounds with both receptor types.

  2004cited by this paper
• Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D

  2004cited by this paper
• Estrogen Receptor β Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest

  2004cited by this paper
• Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells.

  2004cited by this paper
• Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest.

  2004cited by this paper
• Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors α and β by coactivators and corepressors

  2004cited by this paper
• Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors.

  2004cited by this paper
• Not all progestins are the same: implications for usage.

  2004cited by this paper
• Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

  2004cited by this paper
• Phytoestrogens and Their Human Metabolites Show Distinct Agonistic and Antagonistic Properties on Estrogen Receptor α (ERα)and ERβ in Human Cells

  2004cited by this paper
• Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta.

  2003cited by this paper
• Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.

  2003cited by this paper
• Estrogen receptor isoform‐specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERα or ERβ

  2003cited by this paper
• The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression.

  2003cited by this paper
• Sex steroid hormone receptors in human thymoma.

  2003cited by this paper
• Quantitative structure-activity relationships for estrogen receptor binding affinity of phenolic chemicals.

  2003cited by this paper
• Breast cancer and hormone-replacement therapy in the Million Women Study.

  2003cited by this paper
• Study on Interactions of Endocrine Disruptors with Estrogen Receptor-β Using Fluorescence Polarization

  2003cited by this paper
• The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells.

  2003cited by this paper
• The menopause, hormone replacement therapy and breast cancer.

  2002cited by this paper
• Tumour necrosis factor‐α induced CD70 and interleukin‐7R mRNA expression in BEAS‐2B cells

  2002cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• The ligand binding profiles of estrogen receptors alpha and beta are species dependent.

  2002cited by this paper
• Conceptual tensions between quantum mechanics and general relativity: Are there experimental consequences, e.g., superconducting transducers between electromagnetic and gravitational radiation?

  2002cited by this paper
• The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity.

  2002cited by this paper
• Norethisterone acetate in combination with estrogen: effects on the skeleton and other organs. A review.

  2002cited by this paper
• Endocrine and clinical effects of micronized estradiol administered vaginally or orally.

  2001cited by this paper
• Estrogen and rapamycin effects on cell cycle progression in T47D breast cancer cells

  2001cited by this paper
• ERβ Inhibits Proliferation and Invasion of Breast Cancer Cells.

  2001cited by this paper
• Estrogen receptor interaction with estrogen response elements.

  2001cited by this paper
• Characterization of the Physical Interaction between Estrogen Receptor α and JUN Proteins*

  2001cited by this paper
• Natural hormone replacement therapy: what it is and what consumers really want.

  2001cited by this paper
• Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens.

  2001cited by this paper
• A new mathematical model for relative quantification in real-time RT-PCR.

  2001cited by this paper
• Characterization of the physical interaction between estrogen receptor alpha and JUN proteins.

  2001cited by this paper
• Unconventional Estrogens: Estriol, Biest, and Triest

  2001cited by this paper
• Role of estrogen receptor beta in estrogen action.

  2001cited by this paper
• ER beta inhibits proliferation and invasion of breast cancer cells.

  2001cited by this paper
• Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor

  2001cited by this paper
• The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands.

  2000cited by this paper
• Differential estrogen receptor binding of estrogenic substances: a species comparison.

  2000cited by this paper
• Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.

  2000cited by this paper
• The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells.

  2000cited by this paper
• Regulation of estrogen receptor-alpha gene expression by epidermal growth factor.

  2000cited by this paper
• Functional Interaction between the p160 Coactivator Proteins and the Transcriptional Enhancer Factor Family of Transcription Factors*

  2000cited by this paper
• Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1.

  2000cited by this paper
• Identification of a new isoform of the human estrogen receptor‐alpha (hER‐α) that is encoded by distinct transcripts and that is able to repress hER‐α activation function 1

  2000cited by this paper
• The Role of CBP in Estrogen Receptor Cross-Talk with Nuclear Factor-κB in HepG2 Cells.

  2000cited by this paper
• The menopause.

  1999cited by this paper

• Menopause-related changes in vascular signaling by sex hormones.

  2025cites this paper
• Hormone Replacement Therapy and Cardiovascular Health in Postmenopausal Women

  2025cites this paper
• Maternal exposure to fullerenols impairs placental development in mice by inhibiting estriol synthesis and reducing ERα

  2025cites this paper
• Herbal Treatment of Female Urogenital Atrophy: A Retrospective Cohort Analysis

  2024cites this paper
• Electrochemical degradation of 17α-ethinylestradiol: Transformation products, degradation pathways and in vivo assessment of estrogenic activity.

  2023cites this paper
• Click Chemoselective Probe with a Photoswitchable Handle for Highly Sensitive Determination of Steroid Hormones in Food Samples.

  2023cites this paper
• Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective

  2023cites this paper
• Potential therapeutic role for pigment epithelium-derived factor in post-menopausal breast cancer bone metastasis.

  2023cites this paper
• Potential Pathogenic Impact of Cow’s Milk Consumption and Bovine Milk-Derived Exosomal MicroRNAs in Diffuse Large B-Cell Lymphoma

  2023cites this paper
• The steroid hormone estriol (E3) regulates epigenetic programming of fetal mouse brain and reproductive tract

  2022cites this paper
• Combinatorial treatments of tamoxifen and SM6Met, an extract from Cyclopia subternata Vogel, are superior to either treatment alone in MCF-7 cells

  2022cites this paper
• Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha

  2022cites this paper
• Differential off-target glucocorticoid activity of progestins used in endocrine therapy.

  2022cites this paper
• The effect of blind box product uncertainty on consumers’ purchase intention: The mediating role of perceived value and the moderating role of purchase intention

  2022cites this paper
• Behavioral, Physiological, and Molecular Characterization of Long-Term Administration of a Novel Estrogen Receptor Beta Agonist in a Mouse Model of Menopause

  2021cites this paper
• [Estradiol activates ERK phosphorylation by binding to ERβ to inhibit proliferation and promote apoptosis of human chondrocytes].

  2021cites this paper
• Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel

  2021influential citation
• Long‐term hypogonadism diminishes the neuroprotective effects of dietary genistein in young adult ovariectomized rats after transient focal ischemia

  2021cites this paper
• 11-Oxygenated Estrogens Are a Novel Class of Human Estrogens but Do not Contribute to the Circulating Estrogen Pool

  2020cites this paper
• Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception.

  2020cites this paper
• Progestins in menopausal hormone therapy and breast cancer risk: The debate continues

  2020cites this paper
• Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor

  2020cites this paper
• ER subtype selectivity of m-carborane-containing phenols: C-alkyl groups on the m-carborane cage enhance ERα selectivity.

  2019cites this paper
• Happy with the method? : Sexual function changes in young women using contraception

  2019cites this paper
• Hormone Therapy and Breast Cancer: Emerging Steroid Receptor Mechanisms.

  2018cites this paper
• Estriol Reduces Pulmonary Immune Cell Recruitment and Inflammation to Protect Female Mice From Severe Influenza

  2018cites this paper
• Translational opportunities for broad‐spectrum natural phytochemicals and targeted agent combinations in breast cancer

  2018cites this paper
• Investigating the mechanism of action of hormones used in hormone replacement therapy via estrogen receptor subtypes and the influence of the progesterone receptor

  2018influential citation
• The combination of retinoic acid and estrogen can increase germ cells genes expression in mouse embryonic stem cells derived primordial germ cells.

  2018cites this paper
• Memory-Related Synaptic Plasticity Is Sexually Dimorphic in Rodent Hippocampus

  2018cites this paper
• Estrogen Stimulation Differentially Impacts Human Male and Female Antigen-Specific T Cell Anti-Tumor Function and Polyfunctionality

  2017cites this paper
• Estrogen Stimulation Differentially Impacts Human Male and Female Antigen-Specific T Cell Anti-Tumor Function and Polyfunctionality:

  2017cites this paper